TARSUS PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $265.5M
Liabilities Breakdown FY2023
Total Liabilities: $68.5M
Asset Breakdown
Total Assets: $265.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $224.9M | 84.7% |
| Accounts Receivable | $16.6M | 6.3% |
| Inventory | $3.1M | 1.2% |
| Property, Plant & Equipment | $1.5M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $3.9M | 1.5% |
| Other Assets | $15.5M | 5.8% |
Liabilities Breakdown
Total Liabilities: $68.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $17.8M | 25.9% |
| Long-Term Debt | $29.8M | 43.5% |
| Other Liabilities | $20.9M | 30.5% |